Clinical Cancer Research Targets Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hague, S.
Right arrow Articles by Rees, M. C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hague, S.
Right arrow Articles by Rees, M. C. P.
Clinical Cancer Research Vol. 6, 2808-2814, July 2000
© 2000 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Expression of the Hypoxically Regulated Angiogenic Factor Adrenomedullin Correlates with Uterine Leiomyoma Vascular Density1

Stephen Hague, Lyna Zhang, Martin K. Oehler, Sanjiv Manek, Ian Z. MacKenzie, Roy Bicknell and Margaret C. P. Rees2

Nuffield Department of Obstetrics and Gynecology [S. H., L. Z., M. K. O., I. Z. M., M. C. P. R.], Molecular Angiogenesis Laboratory, Imperial Cancer Research Fund, Institute of Molecular Medicine[S. H., L. Z., M. K. O., R. B.], and Department of Cellular Pathology [S. M.], University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom

Uterine leiomyomas are the most prevalent benign tumor type in women of reproductive age and are one of the most common indications for hysterectomy. The expression of five angiogenic factors, adrenomedullin (ADM), vascular endothelial growth factor (VEGF), acidic fibroblast growth factor, basic fibroblast growth factor, and platelet-derived endothelial cell growth factor/thymidine phosphorylase, were examined in 91 uteri collected throughout the menstrual cycle; 52 of which contained leiomyomata, and the remainder were normal controls. The microvascular density and endothelial proliferative indices were then determined for each of the uterine sections. ADM and VEGF were the most widely expressed angiogenic factors in the leiomyomas. Furthermore, the expression of ADM and VEGF in the endometrium and myometrium was up-regulated in leiomyoma-bearing uteri compared with controls. Although acidic fibroblast growth factor and basic fibroblast growth factor were expressed in leiomyomas and endometrium in all of the uterine samples examined, they were only expressed in the myometrium of leiomyomata-bearing uteri. Endothelial proliferation in leiomyomas was statistically greater than that of the myometrium and endometrium, both within and between uteri (P < 0.05). The vascular density in the myometrium but not the endometrium was significantly increased in leiomyoma-containing uteri (P < 0.05). Expression of ADM alone correlated directly with vascular density and endothelial cell proliferation index in leiomyomas and myometrium and may account for the high vascularity found in leiomyomas and the myometrium of leiomyoma-bearing uteri. As such, ADM is identified as a novel target for antiangiogenic therapy of these benign, clinically problematic uterine tumors.




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
D. Ribatti, M. T. Conconi, and G. G. Nussdorfer
Nonclassic Endogenous Novel Regulators of Angiogenesis
Pharmacol. Rev., June 1, 2007; 59(2): 185 - 205.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Aitken, A. Khaund, S.A. Hamid, D. Millan, and S. Campbell
The normal human myometrium has a vascular spatial gradient absent in small fibroids
Hum. Reprod., October 1, 2006; 21(10): 2669 - 2678.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Q. Xu, N. Ohara, W. Chen, J. Liu, H. Sasaki, A. Morikawa, R. Sitruk-Ware, E. D.B. Johansson, and T. Maruo
Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells
Hum. Reprod., September 1, 2006; 21(9): 2408 - 2416.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
T. Maruo, N. Ohara, J. Wang, and H. Matsuo
Sex steroidal regulation of uterine leiomyoma growth and apoptosis
Hum. Reprod. Update, May 1, 2004; 10(3): 207 - 220.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. A. Walocha, J. A. Litwin, and A. J. Miodonski
Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy
Hum. Reprod., May 1, 2003; 18(5): 1088 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.B. Laoag-Fernandez, T. Maruo, P. Pakarinen, I.M. Spitz, and E. Johansson
Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis
Hum. Reprod., April 1, 2003; 18(4): 694 - 699.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. Martinez, M. Vos, L. Guedez, G. Kaur, Z. Chen, M. Garayoa, R. Pio, T. Moody, W. G. Stetler-Stevenson, H. K. Kleinman, et al.
The Effects of Adrenomedullin Overexpression in Breast Tumor Cells
J Natl Cancer Inst, August 21, 2002; 94(16): 1226 - 1237.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Hague, I.Z. MacKenzie, R. Bicknell, and M.C.P. Rees
In-vivo angiogenesis and progestogens
Hum. Reprod., March 1, 2002; 17(3): 786 - 793.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
L.L. Nikitenko, N.S. Brown, D.M. Smith, I.Z. MacKenzie, R. Bicknell, and M.C.P. Rees
Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus
Mol. Hum. Reprod., July 1, 2001; 7(7): 655 - 664.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.